Author

Yi-Chen Lai

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

GLP-1 Receptor Agonists Versus DPP-4 Inhibitors and Incident Dementia Risk in COVID-19 Survivors with Type 2 Diabetes: A Target Trial Emulation Study

Purpose Type 2 diabetes mellitus (T2DM) and COVID-19 are independently associated with an elevated risk of dementia, and COVID-19 survivors with T2DM may represent a clinically vulnerable population in whom metabolic, inflammatory, and vascular factors coexist. However, whether antidiabetic treatment choice is associat...

K.-C. Hung, Ting-Sian Yu, Ping-Hsin Liu et al. · Drug Design, Development and... · 0 citations

Open access Aug 2026

Long-term risk of incident autoimmune thyroid disease after COVID-19 in patients with type 2 diabetes: a multicenter propensity score–matched cohort study

Background Viral infections have been implicated in thyroid autoimmunity, and COVID-19 has emerged as a possible trigger. However, current evidence is mostly limited to case reports and short-term studies evaluating broad thyroid dysfunction rather than autoimmune-specific thyroid disease. This study aimed to evaluate...

K.-C. Hung, Hsiu-Lan Weng, Yi-Chen Lai et al. · Frontiers in Endocrinology · 0 citations

Open access Aug 2026

U-shaped pattern in the association between serum magnesium levels and long-term dementia risk after traumatic brain injury: a retrospective cohort study

Background In the general population, abnormal serum magnesium levels are associated with an increased risk of cognitive decline and dementia. However, whether this association extends to patients with traumatic brain injury (TBI), a population with distinct neurobiological vulnerabilities, remains unknown. Methods Usi...

K.-C. Hung, Hsiu-Lan Weng, Yi-Chen Lai et al. · Frontiers in Nutrition · 0 citations